Regenxbio Inc
NASDAQ:RGNX
Regenxbio Inc
NASDAQ:RGNX
Price:
8.57
USD
-5.62%
Market Closed
Market Cap:
$433.8m
Balance Sheet
Balance Sheet Decomposition
Regenxbio Inc
Regenxbio Inc
Balance Sheet Decomposition is not available for
Regenxbio Inc
Regenxbio Inc
Balance Sheet
Regenxbio Inc
Regenxbio Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
54
|
25
|
47
|
76
|
70
|
338
|
345
|
97
|
35
|
58
|
34
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
1
|
1
|
54
|
25
|
47
|
76
|
70
|
338
|
345
|
97
|
35
|
58
|
34
|
|
| Short-Term Investments |
0
|
0
|
60
|
65
|
114
|
244
|
227
|
137
|
112
|
268
|
241
|
177
|
196
|
|
| Total Receivables |
1
|
2
|
2
|
1
|
1
|
9
|
38
|
43
|
32
|
28
|
25
|
20
|
38
|
|
| Accounts Receivables |
0
|
1
|
2
|
1
|
1
|
9
|
38
|
43
|
32
|
28
|
25
|
20
|
26
|
|
| Other Receivables |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
|
| Other Current Assets |
0
|
0
|
2
|
3
|
7
|
10
|
11
|
13
|
29
|
23
|
35
|
23
|
13
|
|
| Total Current Assets |
2
|
3
|
118
|
93
|
168
|
338
|
345
|
531
|
519
|
416
|
335
|
278
|
281
|
|
| PP&E Net |
0
|
0
|
1
|
9
|
14
|
29
|
39
|
120
|
193
|
207
|
193
|
171
|
152
|
|
| PP&E Gross |
0
|
0
|
1
|
9
|
14
|
29
|
39
|
120
|
193
|
207
|
193
|
171
|
152
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
3
|
7
|
14
|
23
|
29
|
41
|
57
|
72
|
87
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
23
|
4
|
3
|
2
|
2
|
1
|
0
|
2
|
|
| Long-Term Investments |
0
|
0
|
103
|
69
|
16
|
151
|
104
|
47
|
392
|
201
|
39
|
10
|
11
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
3
|
6
|
7
|
9
|
8
|
7
|
6
|
7
|
|
| Total Assets |
3
N/A
|
4
+40%
|
221
+6 226%
|
173
-22%
|
199
+15%
|
544
+174%
|
498
-8%
|
708
+42%
|
1 114
+57%
|
833
-25%
|
574
-31%
|
466
-19%
|
453
-3%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
2
|
5
|
4
|
6
|
11
|
11
|
27
|
23
|
23
|
21
|
|
| Accrued Liabilities |
0
|
1
|
3
|
8
|
10
|
16
|
27
|
48
|
67
|
53
|
57
|
46
|
47
|
|
| Short-Term Debt |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
51
|
34
|
40
|
|
| Other Current Liabilities |
4
|
5
|
0
|
0
|
0
|
1
|
0
|
22
|
53
|
50
|
0
|
0
|
10
|
|
| Total Current Liabilities |
5
|
9
|
4
|
10
|
14
|
22
|
34
|
81
|
131
|
130
|
130
|
103
|
118
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
43
|
25
|
147
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
7
|
14
|
249
|
219
|
187
|
88
|
78
|
85
|
|
| Total Liabilities |
5
N/A
|
9
+96%
|
5
-50%
|
11
+139%
|
16
+42%
|
35
+124%
|
48
+36%
|
330
+593%
|
350
+6%
|
317
-9%
|
262
-17%
|
206
-21%
|
350
+70%
|
|
| Equity | ||||||||||||||
| Common Stock |
23
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
25
|
29
|
52
|
115
|
188
|
83
|
178
|
289
|
161
|
442
|
705
|
932
|
1 126
|
|
| Additional Paid In Capital |
0
|
11
|
269
|
276
|
372
|
593
|
628
|
667
|
928
|
973
|
1 021
|
1 193
|
1 229
|
|
| Other Equity |
0
|
0
|
1
|
0
|
1
|
1
|
0
|
0
|
3
|
15
|
4
|
1
|
1
|
|
| Total Equity |
2
N/A
|
6
-171%
|
217
N/A
|
162
-25%
|
183
+13%
|
509
+178%
|
450
-12%
|
378
-16%
|
764
+102%
|
516
-32%
|
312
-40%
|
260
-17%
|
103
-60%
|
|
| Total Liabilities & Equity |
3
N/A
|
4
+40%
|
221
+6 226%
|
173
-22%
|
199
+15%
|
544
+174%
|
498
-8%
|
708
+42%
|
1 114
+57%
|
833
-25%
|
574
-31%
|
466
-19%
|
453
-3%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
25
|
25
|
26
|
27
|
31
|
36
|
37
|
38
|
43
|
43
|
44
|
50
|
51
|
|
Switch to:
Switch to:
See Also
Discover More
